Sawai Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sawai Pharmaceutical Co., Ltd. with three other
companies in this sector in JAPAN :
Santen Pharmaceutical Company Limited
sales of 241.56 billion Japanese Yen [US$2.30 billion]
of which 93%
was Pharmaceuticals Products),
Rohto Pharmaceutical Co., Ltd.
(188.33 billion Japanese Yen [US$1.79 billion]
of which 61%
was Operating segment-Japan), and
Nichi-Iko Pharmaceutical Company Limited
(190.08 billion Japanese Yen [US$1.81 billion]
of which 82%
was Nichiiko Group).
Sawai Pharmaceutical Co., Ltd. reported sales of ¥182.54 billion (US$1.74 billion)
March of 2020.
decrease of 1.0%
versus 2019, when the company's sales were ¥184.34 billion.
Contributing to the drop in overall sales was the 4.6% decline
in United States, from ¥40.24 billion to ¥38.41 billion.
However, these declines were partially offset by the increase in sales of
Japan (up 0.0% to ¥144.13 billion)